These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21111542)

  • 41. Canine parvovirus immunoprophylaxis: a review.
    Moore DJ
    J S Afr Vet Assoc; 1983 Dec; 54(4):259-64. PubMed ID: 6321731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination.
    Decaro N; Crescenzo G; Desario C; Cavalli A; Losurdo M; Colaianni ML; Ventrella G; Rizzi S; Aulicino S; Lucente MS; Buonavoglia C
    Vaccine; 2014 Jun; 32(30):3850-3. PubMed ID: 24793948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified haemagglutination inhibition assay for the detection of canine parvovirus type 2 antibodies in dog sera.
    Cavalli A; Martella V; Desario C; Camero M; Lanave G; Barrs VR; Decaro N; Buonavoglia C
    Vet J; 2021 Aug; 274():105709. PubMed ID: 34157378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canine parvovirus vaccination.
    Atkinson M
    Vet Rec; 2006 Dec 23-30; 159(26):895; author reply 895-6. PubMed ID: 17189604
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
    van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
    J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials.
    Hernández-Blanco B; Catala-López F
    Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody.
    Burtonboy S; Charlier P; Hertoghs J; Lobmann M; Wiseman A; Woods S
    Vet Rec; 1991 Apr; 128(16):377-81. PubMed ID: 2053262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention of canine parvovirosis - Part 1: Humoral and cellular immunity].
    Bergmann M; Freisl M; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2021 Feb; 49(1):44-50. PubMed ID: 33588464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of vaccination against canine parvovirus.
    Traill P
    Vet Rec; 2006 Nov; 159(20):688. PubMed ID: 17099185
    [No Abstract]   [Full Text] [Related]  

  • 52. Observations on the use of an inactivated canine parvovirus vaccine.
    Smith JR; Johnson RH
    Vet Rec; 1986 Apr; 118(14):385-7. PubMed ID: 3012850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease.
    Yule TD; Roth MB; Dreier K; Johnson AF; Palmer-Densmore M; Simmons K; Fanton R
    Vaccine; 1997; 15(6-7):720-9. PubMed ID: 9178474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of vaccination against canine parvovirus.
    Atkinson M
    Vet Rec; 2006 Sep; 159(13):428; discussion 428. PubMed ID: 16998005
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
    Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
    New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge.
    Wilson S; Stirling C; Borowski S; Thomas A; King V; Salt J
    Vet Rec; 2013 Jun; 172(25):662. PubMed ID: 23748583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years.
    Böhm M; Thompson H; Weir A; Hasted AM; Maxwell NS; Herrtage ME
    Vet Rec; 2004 Apr; 154(15):457-63. PubMed ID: 15119729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure.
    Mittal M; Chakravarti S; Mohapatra JK; Chug PK; Dubey R; Upmanuyu V; Narwal PS; Kumar A; Churamani CP; Kanwar NS
    Infect Genet Evol; 2014 Apr; 23():1-6. PubMed ID: 24486948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of subclinical inflammation on C-reactive protein and haptoglobin levels as well as specific humoral immunity in dogs vaccinated against canine distemper and parvovirus.
    Romiszewski P; Kostro K; Lisiecka U
    BMC Vet Res; 2018 Mar; 14(1):70. PubMed ID: 29506502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma.
    Decaro N; Desario C; Elia G; Campolo M; Lorusso A; Mari V; Martella V; Buonavoglia C
    Vaccine; 2007 Jan; 25(7):1161-6. PubMed ID: 17092616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.